SIGN guidelines Board (External organisation)

Activity: Membership typesMembership of group

Description

SIGN Publication 165: Use of long-acting injectable buprenorphine for opioid substitution therapy. A national position statement. April 2022. Group member
Period30 Jun 202130 Apr 2022